Permanently Discontinued

RAN-NABILONE

RANBAXY PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is RAN-NABILONE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that RAN-NABILONE 0.25MG has been permanently discontinued (last updated July 21, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is RAN-NABILONE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file4 products

Affected strength0.25MG

Last updated2017-07-21

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PMS-NABILONE

PHARMASCIENCE INC

0.25MG · DIN 02380897

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

CESAMET

BAUSCH HEALTH, CANADA INC.

1MG · DIN 00548375

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-NABILONE

TEVA CANADA LIMITED

0.5MG · DIN 02384884

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-NABILONE

APOTEX INC

1MG · DIN 02441519

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02358077

Strength

0.25MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

NABILONE

Tier

Unrated

Last Updated

2017-07-21

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

RAN-NABILONE has 3 shortage/discontinuation reports on file — this is one of them.

2018-06-01

Permanently Discontinued

Business reasons

2018-02-03

Permanently Discontinued

Business reasons

Other Products from RANBAXY PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

RAN-CITALO

40MG · DIN 02285630

RAN-CITALO

20MG · DIN 02285622

RAN-FENTANYL MATRIX PATCH

25MCG · DIN 02330113

RAN-FENTANYL MATRIX PATCH

75MCG · DIN 02330148

RAN-FENTANYL MATRIX PATCH

50MCG · DIN 02330121

RAN-FENTANYL MATRIX PATCH

100MCG · DIN 02330156